"10.1371_journal.pone.0090400","plos one","2014-03-04T00:00:00Z","Ishan Roy; Noah P Zimmerman; A Craig Mackinnon; Susan Tsai; Douglas B Evans; Michael B Dwinell","Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America; Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America","Conceived and designed the experiments: IR MBD. Performed the experiments: IR NPZ ACM. Analyzed the data: IR ACM DBE MBD. Contributed reagents/materials/analysis tools: ACM ST MBD. Wrote the paper: IR ACM DBE MBD.","We have the following interests. Dr. Dwinell is a recipient of a patent (#8,404,640) for the use of CXCL12 in the treatment of malignant cancers and is a co-founder of Protein Foundry, LLC. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The title of the patent is: \"Method of Diagnosing and Treating Colon Cancer\".","2014","03","Ishan Roy","IR",6,TRUE,2,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
